Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elbasvir/Grazoprevir in HCV GT-1b Hemodialysis Patients
NCT03420300Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jun 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of grazoprevir in hepatitis C (HCV), sponsored by National Taiwan University Hospital. Started Jun 2018; status: completed.
02
Drugs
grazoprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03420300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420300.